Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2021

01-06-2021 | Care | Short Research Report

Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation

Authors: Elisabeth Schindler, Ina Richling, Olaf Rose

Published in: International Journal of Clinical Pharmacy | Issue 3/2021

Login to get access

Abstract

Background The drug-related problem classification system of the Pharmaceutical Care Network Europe (PCNE) is well established and continuously updated. A translated version of the drug-related problem classification system can facilitate research and implementation of clinical pharmacy services in the corresponding countries. Aim This study aimed to translate and validate the current version 9.00 into German language. Method The forward–backward translation method was used to translate the English version 9.00 into German language. Validation was done with 20 patient cases. Consistency was calculated in percentage and compared to international results. Results Translation of the classification system yielded in a German version. Validation was done with 32 pharmacists and 20 patient cases. In the five primary domains, average consistencies of 77.3% (problem), 57.8% (cause), 57.4% (intervention), 74.5% (acceptance) and 74.9% (status) were achieved. Ambiguities were found in some patient cases, as raters came to differing but plausible codes. Conclusions This study provides a German translation of the PCNE classification for drug related problems of approximately similar consistency as the international version. It hence can be considered to classify drug-related problems in German speaking countries. Patient cases need to be more specific in future validations, feasibility and layout of the classification system need to improve.
Literature
1.
go back to reference Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed
2.
go back to reference Williams M, Peterson GM, Tenni PC, Bindoff IK, Stafford AC. DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm. 2012;34:43–52.CrossRef Williams M, Peterson GM, Tenni PC, Bindoff IK, Stafford AC. DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm. 2012;34:43–52.CrossRef
3.
go back to reference Maes KA, Tremp RM, Hersberger KE, Lampert ML. Demonstrating the clinical pharmacist’s activity: validation of an intervention oriented classification system. Int J Clin Pharm. 2015;37:1162–71.CrossRef Maes KA, Tremp RM, Hersberger KE, Lampert ML. Demonstrating the clinical pharmacist’s activity: validation of an intervention oriented classification system. Int J Clin Pharm. 2015;37:1162–71.CrossRef
4.
go back to reference van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.CrossRef van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.CrossRef
5.
go back to reference Horvat N, Kos M. Development and validation of the Slovenian drug-related problem classification system based on the PCNE classification V 6.2. Int J Clin Pharm. 2016;38:950–9.CrossRef Horvat N, Kos M. Development and validation of the Slovenian drug-related problem classification system based on the PCNE classification V 6.2. Int J Clin Pharm. 2016;38:950–9.CrossRef
6.
go back to reference Eichenberger PM, Lampert ML, Kahmann IV, van Mil JWF, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32:362–72.CrossRef Eichenberger PM, Lampert ML, Kahmann IV, van Mil JWF, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32:362–72.CrossRef
7.
go back to reference Koubaity M, Lelubre M, Sansterre G, Amighi K, Vriese C de. Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies. Int J Clin Pharm. 2019;41:244–50.CrossRef Koubaity M, Lelubre M, Sansterre G, Amighi K, Vriese C de. Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies. Int J Clin Pharm. 2019;41:244–50.CrossRef
Metadata
Title
Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation
Authors
Elisabeth Schindler
Ina Richling
Olaf Rose
Publication date
01-06-2021
Publisher
Springer International Publishing
Keyword
Care
Published in
International Journal of Clinical Pharmacy / Issue 3/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01150-w

Other articles of this Issue 3/2021

International Journal of Clinical Pharmacy 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.